Xeber.world
FDA Commissioner Marty Makary resigns after months of internal scrutiny, with Kyle Diamantas stepping in as acting commissioner. Meanwhile, Eli Lilly'...
Pharmaceutical companies backing TrumpRx spent over $130 million on federal lobbying in 2025, a 23% surge. Eli Lilly paused its obesity awareness camp...
Seaport Therapeutics CEO Daphne Zohar joins the 400th episode of 'The Readout LOUD' to discuss the biotech's successful IPO. The episode also covers t...
Novo Nordisk’s new weight-loss pill, Wegovy, has achieved 1.3 million prescriptions in Q1 2026, prompting the company to raise its full-year guidance....
Novo Nordisk revised its 2024 sales and operating profit guidance upward following strong performance of its Wegovy obesity drug. The Danish pharma gi...
Vertex Pharma halts early-stage mRNA cystic fibrosis therapy VX-522 due to tolerability issues. Cytokinetics’ Myqorzo meets dual efficacy goals in gen...
France’s medicines regulator has fined Novo Nordisk $2 million and Eli Lilly $127,000 for allegedly misleading advertisements for their weight loss dr...
The FDA has proposed excluding semaglutide and tirzepatide, key ingredients in popular weight-loss and diabetes drugs like Wegovy, Ozempic, Mounjaro,...
Boehringer’s investigational obesity drug demonstrated a 16.6% weight loss in a clinical trial, outperforming many existing treatments. However, addit...
Eli Lilly has partnered with AI-focused biotech Profluent to develop advanced gene editors capable of inserting entire genes into patients. The deal i...
Astellas is reentering clinical trials for its next-generation XLMTM gene therapy following patient deaths. Eli Lilly acquires Ajax Therapeutics for u...
Eli Lilly has agreed to acquire Kelonia Therapeutics, a cancer and autoimmune cell therapy startup, for $3.2 billion with potential milestone payments...
Kelonia Therapeutics, a CAR-T biotech on the brink of collapse three times, was acquired by Eli Lilly for $3.25 billion. The deal highlights the secto...
The Trump administration's Medicare obesity drug pilot was abandoned after insurers declined to participate. Meanwhile, Amazon's One Medical is launch...
The Trump administration proposed a Medicare pilot program to offer discounted weight loss drugs to seniors, but insurers declined participation. As a...
The FDA has granted fast-track approval to Foundayo, a once-daily GLP-1 pill for weight loss developed by Eli Lilly. The medication, designed for adul...
Amazon has expanded access to Eli Lilly’s new GLP-1 weight loss pill, Foundayo, through its One Medical kiosks and same-day delivery services. The pil...